Use of prescription weight loss pills among US adults in 1996-1998

Background: Pharmacotherapy is recommended for the treatment of obese perso ns with a body mass index of 30 kg/m(2) or higher or a body mass index of a t least 27 kg/m(2) plus an obesity-related comorbid condition. Objective: To estimate the prevalence of use of prescription weight loss pi lls in the United States in 1996-1998. Design: 1998 Behavioral Risk Factor Surveillance System, a nationally repre sentative telephone survey. Setting: United States. Participants: 139 779 adults 18 years of age and older. Measurements: Self-reported pill use for 1996-1998, body mass index (curren t and before pill use), age, sex, and race or ethnicity. Results: The 2-year prevalence of pill use was 2.5% (95% CI, 2.1% to 2.9%); or 4.6 million U.S. adults. Use was higher in women than in men (4.0% vs. 0.9%, respectively) and highest among Hispanic respondents (3.2%). Of pill users, 25% were not overweight (body mass index < 27 kg/m(2)) before using pills. Conclusions: Nearly 5 million U.S. adults used prescription weight loss pil ls in 1996-1998. However, one quarter of users were not overweight. suggest ing that weight loss pills may be inappropriately used, especially among wo men, white persons, and Hispanic persons.